Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
EVMN compared with OCS: revenue, margins and what each company keeps, and the suppliers and customers both name
EVMN
Evommune, Inc.
Change
Mkt cap
Revenue
Revenue
OCS
Oculis Holding AG
Change
Mkt cap
Revenue
Revenue
vs
Compare
EVMN
Evommune, Inc.
vs
OCS
Oculis Holding AG
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
EVMN: latest quarter is a loss; flow not drawable. OCS: latest quarter not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
EVMN, solid
OCS, dashed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only EVMN
5
—
AprilBio
unlisted
supplier
—
Dermira
unlisted
supplier
—
BDO USA, P.C
unlisted
supplier
—
Hudson Page Mill Hill
unlisted
supplier
1 more · EVMN chain
›
Shared
0
No disclosed counterparties: OCS.
Only OCS
0
None
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
EVMN
Evommune, Inc.
Change
6.72
· pre 6.72
· delayed
Mkt cap
$243.2M
Revenue
$10M
Q3 FY25
OCS
Oculis Holding AG
Change
8.28
· pre 8.28
· delayed
Pre-market
Oct 30 '26
delayed
Mkt cap
$496.3M
Revenue
—
vs
Compare
Pre-market
Oct 30 '26
delayed
EVMN
Evommune, Inc.
vs
OCS
Oculis Holding AG
6.72
pre 6.72
delayed
Price
8.28
pre 8.28
delayed
$243.2M
Mkt cap
$496.3M
Q3 FY25
$10M
Revenue
—
Change
Change
EVMN
6.72
vs
OCS
8.28
Pre-market
Oct 30 '26
delayed